Dihidroergotamina [INN-Spanish] en es it fr

Dihidroergotamina [INN-Spanish] Brand names, Dihidroergotamina [INN-Spanish] Analogs

Dihidroergotamina [INN-Spanish] Brand Names Mixture

  • No information avaliable

Dihidroergotamina [INN-Spanish] Chemical_Formula

C33H37N5O5

Dihidroergotamina [INN-Spanish] RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Dihidroergotamina [INN-Spanish] fda sheet

Dihidroergotamina_[INN-Spanish] FDA

Dihidroergotamina [INN-Spanish] msds (material safety sheet)

Dihidroergotamina_[INN-Spanish] MSDS

Dihidroergotamina [INN-Spanish] Synthesis Reference

No information avaliable

Dihidroergotamina [INN-Spanish] Molecular Weight

583.678 g/mol

Dihidroergotamina [INN-Spanish] Melting Point

No information avaliable

Dihidroergotamina [INN-Spanish] H2O Solubility

No information avaliable

Dihidroergotamina [INN-Spanish] State

Solid

Dihidroergotamina [INN-Spanish] LogP

No information avaliable

Dihidroergotamina [INN-Spanish] Dosage Forms

Liquid

Dihidroergotamina [INN-Spanish] Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Dihidroergotamina [INN-Spanish] Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Dihidroergotamina [INN-Spanish] Absorption

Interpatient variable and may be dependent on the administration technique

Dihidroergotamina [INN-Spanish] side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Dihidroergotamina [INN-Spanish] Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45 (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Dihidroergotamina [INN-Spanish] Organisms Affected

Humans and other mammals